EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 07 listopada 2024. Database contains 4691 unique substances/entries.

Filter the list

Prikazano 3.451 - 3.500 od 4.691 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride CLEARFRAC J508B	426-210-6	120086-58-0	Skin Corr. 1B
disodium octaborate anhydrous	234-541-0	12008-41-2	Repr. 1B
trinickel boride	234-495-1	12007-02-2	Carc. 1A; STOT RE 1; Skin Sens. 1
dinickel boride	234-494-6	12007-01-1	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel boride (NiB)	234-493-0	12007-00-0	Carc. 1A; STOT RE 1; Skin Sens. 1
fipronil (ISO); (±)-5-amino-1-(2,6-dichloro-α,α,α-trifluoro-para-tolyl)-4-trifluoromethylsulfinyl-pyrazole-3-carbonitrile	424-610-5	120068-37-3	Acute Tox. 3; STOT RE 1
dialuminium nickel tetraoxide	234-454-8	12004-35-2	Carc. 1A; STOT RE 1; Skin Sens. 1
trimagnesium;hydroxy(trioxido)silane;hydrate	601-650-3	12001-29-5	Carc. 1A; STOT RE 1
trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+)	601-649-8	12001-28-4	Carc. 1A; STOT RE 1
cyclopentanone	204-435-9	120-92-3	Flam. Liq. 3; Eye Irrit. 2; Skin Irrit. 2
2,4-dichlorophenol	204-429-6	120-83-2	Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B
1,2,4-trichlorobenzene	204-428-0	120-82-1	Acute Tox. 4; Skin Irrit. 2
1,2-dihydroxybenzene; pyrocatechol	204-427-5	120-80-9	Carc. 1B; Muta. 2; Acute Tox. 3; Eye Irrit. 2; Skin Irrit. 2
di(benzothiazol-2-yl) disulphide	204-424-9	120-78-5	Skin Sens. 1
6-methoxy-m-toluidine; p-cresidine	204-419-1	120-71-8	Carc. 1B; Acute Tox. 4
benzyl benzoate	204-402-9	120-51-4	Acute Tox. 4
dichlorprop (ISO); 2-(2,4-dichlorophenoxy)propionic acid	204-390-5	120-36-5	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
clorofene; chlorophene; 2-benzyl-4-chlorophenol	204-385-8	120-32-1	Carc. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1; Eye Dam. 1; STOT RE 2
methyl 3-amino-4,6-dibromo-2-methyl-benzoate	425-190-6	119916-05-1	STOT RE 2
quizalofop-P-tefuryl (ISO); (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate PANTERA; QUIZALOFOP-P-TEFURYL	414-200-4	119738-06-6	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2
trisodium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionate TRILON(R) ES 9910	414-130-4	119710-96-2	Acute Tox. 4
reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate VP SANDUVOR 3052 LIQUIDE	405-670-1	119530-69-7	Acute Tox. 4; STOT RE 2; Skin Corr. 1B
1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene PERKALINK 900	412-570-1	119462-56-5	STOT RE 2; Eye Dam. 1; Skin Sens. 1
difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl} methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl] phenyl 4-chlorophenyl ether	601-613-1	119446-68-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2
C12-14-tert-alkylamine, methylphosphonic acid salt CD 23-404	404-750-3	119415-07-5	Acute Tox. 4; Skin Corr. 1B
dichlobenil (ISO); 2,6-dichlorobenzonitrile	214-787-5	1194-65-6	Acute Tox. 4
2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone CG 25-369; IRGACURE 369; TK 11-319	404-360-3	119313-12-1	Repr. 1B
sodium (R)-2-(2,4-dichlorophenoxy)propionate DUPLOSAN-DP-NATRIUM; DUPOLSON-DP-NATRIUM	413-340-3	119299-10-4	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide	601-585-0	119168-77-3	Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Sens. 1B
2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride 31 AC-HCL	410-620-7	119154-86-8	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
4,4'-bi-o-toluidine	204-358-0	119-93-7	Carc. 1B; Acute Tox. 4
3,3'-dimethoxybenzidine; o-dianisidine	204-355-4	119-90-4	Carc. 1B; Acute Tox. 4
1,2,3,4-tetrahydronaphthalene	204-340-2	119-64-2	Eye Irrit. 2; Skin Irrit. 2
benzophenone	204-337-6	119-61-9	Carc. 1B
6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol; [DBMC]	204-327-1	119-47-1	Repr. 1B
1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; isolan	204-318-2	119-38-0	Acute Tox. 1; Acute Tox. 2
methyl salicylate	204-317-7	119-36-8	Repr. 2; Acute Tox. 4; Skin Sens. 1B
(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid CARTASOL TUERKIS K-ZBL KONC.; CARTASOL TURQUOISE K-JD 2336; CARTASOL TURQUOISE K-JD 2336 CONC.; CARTASOL TURQUOISE K-ZBL CONC.; CARTASOL TÜRKIS K-ZBL FLÜSSIG; CARTASOL TÜRKIS K-ZBL KONZ.; TURQUOISE CARTASOL K-JD 2336 CONC.	401-260-1	118800-27-4	Eye Irrit. 2
A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide CCA-VERSUCHSPRODUKT SN 4001	405-080-4	118725-24-9	Eye Dam. 1
transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	405-060-5	118712-89-3	Carc. 2; Acute Tox. 4; STOT SE 1
sodium 5-n-butylbenzotriazole COBRATEC 435	404-450-2	118685-34-0	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-); trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) AZUL MARINHO 018112; BLEU MARINE 018112; NAVY 018112; NAVY BLUE 018112	405-665-4	118685-33-9	Skin Sens. 1
(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'dipyridinium dichloride dihydrochloride CARTASOL GEEL M-GL CONC.; CARTASOL GELB M-GL FLÜSSIG (ZUBEREITUNG); CARTASOL GELB M-GL KONZ.; CARTASOL YELLOW M-GL CONC.; HM 2580	401-500-5	118658-99-4	Carc. 1B
reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) CARTASOL RED K-2BN; RED 10 25 501	408-000-6	118658-98-3	STOT RE 2; Skin Sens. 1
N, N-dimethylanilinium tetrakis(pentafluorophenyl)borate B1; N,N-DIMETHYLANILINUM TETRAKIS(PENTAFLUOROPHENYL)BORATE; TÉTRAKIS(PENTAFLUOROPHÉNYL)BORATE DE N,N-DIMÉTHYLANILINIUM	422-050-6	118612-00-3	Carc. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate C.I. DISPERSE BLUE 356	400-460-6	118578-14-6	Skin Sens. 1
disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) SÄUREBRAUN 8507	404-930-1	118556-91-5	Acute Tox. 4; Eye Dam. 1
2,4-bis[2,2'-[2-(N, N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride BASISCH GELB 8511	407-010-8	118208-02-9	Acute Tox. 4; Eye Dam. 1
spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine	601-505-4	118134-30-8	Repr. 2; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Skin Sens. 1
(2R, 3S, 4R, 5R, 7R, 9R, 10R,11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane	433-820-6	118058-74-5	Eye Irrit. 2

Prikazano 3.451 - 3.500 od 4.691 rezultata.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 07 listopada 2024. Database contains 4691 unique substances/entries.

Footer Nav Items